OS Therapies Incorporated OSTX
1.15 USD -0.01 (-1.29%)
Nov 4, 2026, 3:51 PM EST
1.11 Day range 1.21
1.11 52-week range 2.25
- YTD
- -18.21%
- 1 year
- -35.67%
Financial health
Altman Z-Score
-25.76 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -1.4×
FY 2020 5y median -7.6× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B -6.7×
FY 2020 5y median -3.3× FY 2025
P/FCF -0.0×
FY 2020 5y median -13.1× FY 2025
EV/EBITDA -1.4×
FY 2020 5y median -13.4× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -34767.1%
FY 2020 5y median -7.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE 471.7%
FY 2020 5y median 35.6% FY 2025
ROIC 582.9%
FY 2020 5y median 78.9% FY 2025
ROA -420.4%
FY 2020 5y median -976.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income -321.3%
FY 2020 FY 2025
EPS (diluted) -88.5%
FY 2020 FY 2025
Free Cash Flow -195423.2%
FY 2020 FY 2025
Financial Health
Current Ratio 0.0×
FY 2020 5y median 0.1× FY 2025
Quick Ratio 0.0×
FY 2020 5y median 0.1× FY 2025
Debt / Equity 0.0×
FY 2020 5y median -0.6× FY 2025
Net Debt / EBITDA 0.0×
FY 2020 5y median -1.4× FY 2025
Interest Coverage 0.0×
FY 2020 5y median -1.9× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31